Cargando…

Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort

Background: To fight the COVID-19 pandemic, immunity against SARS-CoV-2 should be achieved not only through natural infection but also by vaccination. The effect of COVID-19 vaccination on previously infected persons is debatable. Methods: A prospective cohort was undergone to collect sera from unva...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurisyah, Sitti, Iyori, Mitsuhiro, Hasyim, Ammar Abdurrahman, Sakamoto, Akihiko, Hashimoto, Hinata, Yamagata, Kyouhei, Yamauchi, Saya, Amru, Khaeriah, Zainal, Kartika Hardianti, Idris, Irfan, Yoshida, Shigeto, Djaharuddin, Irawaty, Syafruddin, Din, Bukhari, Agussalim, Asih, Puji Budi Setia, Yusuf, Yenni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526084/
https://www.ncbi.nlm.nih.gov/pubmed/37753974
http://dx.doi.org/10.3390/antib12030060
_version_ 1785110938219708416
author Nurisyah, Sitti
Iyori, Mitsuhiro
Hasyim, Ammar Abdurrahman
Sakamoto, Akihiko
Hashimoto, Hinata
Yamagata, Kyouhei
Yamauchi, Saya
Amru, Khaeriah
Zainal, Kartika Hardianti
Idris, Irfan
Yoshida, Shigeto
Djaharuddin, Irawaty
Syafruddin, Din
Bukhari, Agussalim
Asih, Puji Budi Setia
Yusuf, Yenni
author_facet Nurisyah, Sitti
Iyori, Mitsuhiro
Hasyim, Ammar Abdurrahman
Sakamoto, Akihiko
Hashimoto, Hinata
Yamagata, Kyouhei
Yamauchi, Saya
Amru, Khaeriah
Zainal, Kartika Hardianti
Idris, Irfan
Yoshida, Shigeto
Djaharuddin, Irawaty
Syafruddin, Din
Bukhari, Agussalim
Asih, Puji Budi Setia
Yusuf, Yenni
author_sort Nurisyah, Sitti
collection PubMed
description Background: To fight the COVID-19 pandemic, immunity against SARS-CoV-2 should be achieved not only through natural infection but also by vaccination. The effect of COVID-19 vaccination on previously infected persons is debatable. Methods: A prospective cohort was undergone to collect sera from unvaccinated survivors and vaccinated persons—with and without COVID-19 pre-infection. The sera were analyzed for the anti-receptor binding domain (RBD) titers by ELISA and for the capacity to neutralize the pseudovirus of the Wuhan-Hu-1 strain by luciferase assays. Results: Neither the antibody titers nor the neutralization capacity was significantly different between the three groups. However, the correlation between the antibody titers and the percentage of viral neutralization derived from sera of unvaccinated survivors was higher than that from vaccinated persons with pre-infection and vaccinated naïve individuals (Spearman correlation coefficient (r) = −0.8558; 95% CI, −0.9259 to −0.7288), p < 0.0001 vs. −0.7855; 95% CI, −0.8877 to −0.6096, p < 0.0001 and −0.581; 95% CI, −0.7679 to −0.3028, p = 0.0002, respectively), indicating the capacity to neutralize the virus is most superior by infection alone. Conclusions: Vaccines induce anti-RBD titers as high as the natural infection with lower neutralization capacity, and it does not boost immunity in pre-infected persons.
format Online
Article
Text
id pubmed-10526084
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105260842023-09-28 Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort Nurisyah, Sitti Iyori, Mitsuhiro Hasyim, Ammar Abdurrahman Sakamoto, Akihiko Hashimoto, Hinata Yamagata, Kyouhei Yamauchi, Saya Amru, Khaeriah Zainal, Kartika Hardianti Idris, Irfan Yoshida, Shigeto Djaharuddin, Irawaty Syafruddin, Din Bukhari, Agussalim Asih, Puji Budi Setia Yusuf, Yenni Antibodies (Basel) Article Background: To fight the COVID-19 pandemic, immunity against SARS-CoV-2 should be achieved not only through natural infection but also by vaccination. The effect of COVID-19 vaccination on previously infected persons is debatable. Methods: A prospective cohort was undergone to collect sera from unvaccinated survivors and vaccinated persons—with and without COVID-19 pre-infection. The sera were analyzed for the anti-receptor binding domain (RBD) titers by ELISA and for the capacity to neutralize the pseudovirus of the Wuhan-Hu-1 strain by luciferase assays. Results: Neither the antibody titers nor the neutralization capacity was significantly different between the three groups. However, the correlation between the antibody titers and the percentage of viral neutralization derived from sera of unvaccinated survivors was higher than that from vaccinated persons with pre-infection and vaccinated naïve individuals (Spearman correlation coefficient (r) = −0.8558; 95% CI, −0.9259 to −0.7288), p < 0.0001 vs. −0.7855; 95% CI, −0.8877 to −0.6096, p < 0.0001 and −0.581; 95% CI, −0.7679 to −0.3028, p = 0.0002, respectively), indicating the capacity to neutralize the virus is most superior by infection alone. Conclusions: Vaccines induce anti-RBD titers as high as the natural infection with lower neutralization capacity, and it does not boost immunity in pre-infected persons. MDPI 2023-09-21 /pmc/articles/PMC10526084/ /pubmed/37753974 http://dx.doi.org/10.3390/antib12030060 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nurisyah, Sitti
Iyori, Mitsuhiro
Hasyim, Ammar Abdurrahman
Sakamoto, Akihiko
Hashimoto, Hinata
Yamagata, Kyouhei
Yamauchi, Saya
Amru, Khaeriah
Zainal, Kartika Hardianti
Idris, Irfan
Yoshida, Shigeto
Djaharuddin, Irawaty
Syafruddin, Din
Bukhari, Agussalim
Asih, Puji Budi Setia
Yusuf, Yenni
Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
title Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
title_full Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
title_fullStr Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
title_full_unstemmed Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
title_short Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
title_sort comparison between neutralization capacity of antibodies elicited by covid-19 natural infection and vaccination in indonesia: a prospective cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526084/
https://www.ncbi.nlm.nih.gov/pubmed/37753974
http://dx.doi.org/10.3390/antib12030060
work_keys_str_mv AT nurisyahsitti comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT iyorimitsuhiro comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT hasyimammarabdurrahman comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT sakamotoakihiko comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT hashimotohinata comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT yamagatakyouhei comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT yamauchisaya comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT amrukhaeriah comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT zainalkartikahardianti comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT idrisirfan comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT yoshidashigeto comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT djaharuddinirawaty comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT syafruddindin comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT bukhariagussalim comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT asihpujibudisetia comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort
AT yusufyenni comparisonbetweenneutralizationcapacityofantibodieselicitedbycovid19naturalinfectionandvaccinationinindonesiaaprospectivecohort